Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis

ObjectiveAutoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a novel steroid sensitive autoimmune disease, without a diagnostic consensus. The purpose of this study was to improve early GFAP-A diagnosis by increasing awareness of key clinical characteristics and imaging manifestati...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaomeng Li, Jiacun Li, Han Xu, Xiaohui Liu, Meilin Li, Jingzhen He, Jianjun Xiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466847/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850246002951323648
author Xiaomeng Li
Jiacun Li
Han Xu
Xiaohui Liu
Meilin Li
Jingzhen He
Jianjun Xiu
author_facet Xiaomeng Li
Jiacun Li
Han Xu
Xiaohui Liu
Meilin Li
Jingzhen He
Jianjun Xiu
author_sort Xiaomeng Li
collection DOAJ
description ObjectiveAutoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a novel steroid sensitive autoimmune disease, without a diagnostic consensus. The purpose of this study was to improve early GFAP-A diagnosis by increasing awareness of key clinical characteristics and imaging manifestations.MethodsMedical records of 13 patients with anti-GFAP antibodies in serum or cerebrospinal fluid (CSF) were reviewed for cross-sectional and longitudinal analysis of clinical and magnetic resonance imaging (MRI) findings.ResultsThe predominant GFAP-A clinical manifestations are limb weakness/numbness and fever. GFAP-A has a propensity in the early stage for meningeal and leptomeningeal lesions on the brainstem surface, with a typical pattern of periventricular linear radial and leptomeningeal enhancement. The clinical manifestations and leptomeningeal enhancement were rapidly alleviated after treatment with high doses of corticosteroids or/and intravenous immunoglobulin, although, there are patients who may present with increased brain parenchymal lesions. On 3T MRI, the spinal cord demonstrated extensive longitudinal T2-weighted hyper-intensity, central distribution, and gray matter involvement. Optic nerve involvement in some patients was also noted with optic nerve swelling and abnormal enhancement. In addition to the classic reversible splenium of corpus callosum syndrome (type I), this study found the much rarer type II with diffusion restriction on DWI (Diffusion Weighted Imaging) in the corpus callosum. Positive anti-GFAP antibodies in serum or cerebrospinal fluid (CSF) are important for GFAP-A diagnosis with overlapping antibodies commonly noted. This study found anti-GM3 antibodies, a rare finding also previously reported.ConclusionThis study correlates GFAP-A clinical and imaging features, noting a “delay” phenomenon between clinical manifestations, treatment response, and radiographic MRI findings. MRI T2-FLAIR brainstem hyperintensity and T2-FLAIR gadolinium enhanced images, and subtraction techniques were valuable for early lesion detection and accurate diagnosis.
format Article
id doaj-art-906505bc90c8455eb73fed53df0ec2a2
institution OA Journals
issn 1664-3224
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-906505bc90c8455eb73fed53df0ec2a22025-08-20T01:59:17ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.14668471466847Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosisXiaomeng Li0Jiacun Li1Han Xu2Xiaohui Liu3Meilin Li4Jingzhen He5Jianjun Xiu6Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Radiology, People’s Hospital of RiZhao, RiZhao, Shandong, ChinaDepartment of Radiology, Jinan Third People’s Hospital, Jinan, Shandong, ChinaDepartment of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, ChinaDepartment of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaObjectiveAutoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a novel steroid sensitive autoimmune disease, without a diagnostic consensus. The purpose of this study was to improve early GFAP-A diagnosis by increasing awareness of key clinical characteristics and imaging manifestations.MethodsMedical records of 13 patients with anti-GFAP antibodies in serum or cerebrospinal fluid (CSF) were reviewed for cross-sectional and longitudinal analysis of clinical and magnetic resonance imaging (MRI) findings.ResultsThe predominant GFAP-A clinical manifestations are limb weakness/numbness and fever. GFAP-A has a propensity in the early stage for meningeal and leptomeningeal lesions on the brainstem surface, with a typical pattern of periventricular linear radial and leptomeningeal enhancement. The clinical manifestations and leptomeningeal enhancement were rapidly alleviated after treatment with high doses of corticosteroids or/and intravenous immunoglobulin, although, there are patients who may present with increased brain parenchymal lesions. On 3T MRI, the spinal cord demonstrated extensive longitudinal T2-weighted hyper-intensity, central distribution, and gray matter involvement. Optic nerve involvement in some patients was also noted with optic nerve swelling and abnormal enhancement. In addition to the classic reversible splenium of corpus callosum syndrome (type I), this study found the much rarer type II with diffusion restriction on DWI (Diffusion Weighted Imaging) in the corpus callosum. Positive anti-GFAP antibodies in serum or cerebrospinal fluid (CSF) are important for GFAP-A diagnosis with overlapping antibodies commonly noted. This study found anti-GM3 antibodies, a rare finding also previously reported.ConclusionThis study correlates GFAP-A clinical and imaging features, noting a “delay” phenomenon between clinical manifestations, treatment response, and radiographic MRI findings. MRI T2-FLAIR brainstem hyperintensity and T2-FLAIR gadolinium enhanced images, and subtraction techniques were valuable for early lesion detection and accurate diagnosis.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466847/fullautoimmune glial fibrillary acidic protein astrocytopathymeningeal enhancementbrain FLAIR gadolinium enhancementspinal cord longitudinal T2 hyperintensityoverlapping antibodies
spellingShingle Xiaomeng Li
Jiacun Li
Han Xu
Xiaohui Liu
Meilin Li
Jingzhen He
Jianjun Xiu
Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
Frontiers in Immunology
autoimmune glial fibrillary acidic protein astrocytopathy
meningeal enhancement
brain FLAIR gadolinium enhancement
spinal cord longitudinal T2 hyperintensity
overlapping antibodies
title Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
title_full Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
title_fullStr Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
title_full_unstemmed Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
title_short Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
title_sort review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
topic autoimmune glial fibrillary acidic protein astrocytopathy
meningeal enhancement
brain FLAIR gadolinium enhancement
spinal cord longitudinal T2 hyperintensity
overlapping antibodies
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466847/full
work_keys_str_mv AT xiaomengli reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT jiacunli reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT hanxu reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT xiaohuiliu reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT meilinli reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT jingzhenhe reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis
AT jianjunxiu reviewofclinicalandimagingfindingsinautoimmuneglialfibrillaryacidicproteinastrocytopathytoaidinearlydiagnosis